PA
BPMC

Profund Advisors’s Blueprint Medicines BPMC Stock Holding History

Profund Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,210
Closed -$1.69M – 1058
2025
Q2 		$1.69M Sell
13,210
-7,630
-37% -$792K 0.06% 208
2025
Q1 		$1.84M Buy
20,840
+3,094
+17% +$302K 0.08% 193
2024
Q4 		$1.55M Sell
17,746
-5,704
-24% -$522K 0.06% 220
2024
Q3 		$2.17M Buy
23,450
+5,336
+29% +$530K 0.08% 177
2024
Q2 		$1.95M Buy
18,114
+1,739
+11% +$174K 0.07% 181
2024
Q1 		$1.55M Sell
16,375
-4,253
-21% -$365K 0.06% 217
2023
Q4 		$1.9M Sell
20,628
-8,035
-28% -$521K 0.08% 180
2023
Q3 		$1.44M Buy
28,663
+2,225
+8% +$119K 0.08% 196
2023
Q2 		$1.67M Sell
26,438
-4,162
-14% -$226K 0.09% 180
2023
Q1 		$1.38M Buy
30,600
+22,502
+278% +$1.01M 0.09% 202
2022
Q4 		$355K Buy
8,098
+170
+2% +$8.15K 0.02% 556
2022
Q3 		$522K Sell
7,928
-149
-2% -$9.57K 0.04% 376
2022
Q2 		$408K Sell
8,077
-985
-11% -$57.7K 0.03% 494
2022
Q1 		$579K Sell
9,062
-1,008
-10% -$72.4K 0.02% 479
2021
Q4 		$1.08M Sell
10,070
-1,141
-10% -$119K 0.04% 310
2021
Q3 		$1.15M Sell
11,211
-464
-4% -$43.2K 0.04% 312
2021
Q2 		$1.03M Sell
11,675
-227
-2% -$20.8K 0.03% 356
2021
Q1 		$1.16M Sell
11,902
-635
-5% -$63.4K 0.04% 278
2020
Q4 		$1.41M Buy
12,537
+1,276
+11% +$134K 0.06% 250
2020
Q3 		$1.04M Sell
11,261
-1,649
-13% -$127K 0.05% 271
2020
Q2 		$1.01M Buy
12,910
+2,925
+29% +$198K 0.06% 269
2020
Q1 		$584K Sell
9,985
-4,093
-29% -$263K 0.04% 321
2019
Q4 		$1.13M Buy
14,078
+1,749
+14% +$131K 0.05% 319
2019
Q3 		$906K Buy
+12,329
New +$1.07M 0.05% 349

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Profund Advisors's BPMC Position: Q3 2025 in Review

Profund Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 13,210 shares — an estimated $1.69M sold.

Profund Advisors first reported a position in BPMC in Q3 2019 and held it in 24 quarters. The position peaked at $2.17M in Q3 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Profund Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Profund Advisors sold 13,210 Blueprint Medicines shares in Q3 2025, an estimated $1.69M.
  • Profund Advisors first reported a position in Blueprint Medicines in Q3 2019 and held it in 24 quarters.
  • Profund Advisors's Blueprint Medicines position peaked at $2.17M in Q3 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Profund Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.